NEWS

Our research using TBP1901, a drug we have developed, has been selected for the “Research Project for Practical Application of Innovative...

We have renewed video article on the clinical studies on (1) immune function and COVID-19 , (2) heart failure , and (3) knee...

Spring is a time of seasonal change, and the temperature difference is large, so it's easy to get sick. There are also many events and...

On June 24, 2024, a paper on COVID-19 infection in curcuRouge® has been published in the Journal of Health, Population and Nutrition. A...

On March 31, 2024, the 144th Annual Meeting of the Pharmaceutical Society of Japan/Sera Bio-Pharma Co. held a luncheon seminar (seminar...

curcuRouge® has succeeded in proofing a potential for treating human knee osteoarthritis, particularly at an early stage.